Human medicines
Valsartan/HCT from Teva B.V.
The marketing authorization holder informed its supplied customers in a letter dated November 23, 2018, that the active ingredient manufacturer Mylan…
Production-related contamination with N-nitrosodiethylamine (NDEA) in the active ingredient valsartan from the manufacturer "Mylan Laboratory Limited".
Novalgin
The marketing authorization holder has informed its supplied customers in a letter dated November 16, 2018, that isolated impurities or contamination…
Rapibloc
The marketing authorization holder has informed its supplied customers by letter dated Nov. 12, 2018, that due to a slightly increased exceedance of…
Recall of Jakavi 15 mg tablets due to suspected counterfeiting
BCG, mitomycin, mito-extra
The marketing authorization holder informed the supplied customers via its distribution partner in a letter dated 01.10.2018 that the urology…
Jakavi
The parallel distributor - "HAEMATO PHARM GmbH" - informed its supplied customers in a letter dated October 8, 2018, that for the two batches of…
Robinul
The marketing authorization holder informed its supplied customers in a letter dated August 16, 2018, that due to quality problems with one batch of…
CO-Valsax and Valsartan-HCT from G.L. Pharma GmbH
The marketing authorization holder informed its supplied customers in a letter dated July 5, 2018, that a production-related impurity occurred at the…
Valsartan medication review - update.
